Boundless Bio, precision oncology company developing therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers, $100M Series C with Leaps by Bayer, RA Capital Management
Ray Therapeutics, biotech company developing optogenetic gene therapies for patients with blinding diseases, $100M Series A with Novo Holdings
Cullgen, drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies, $35M Series C with AstraZeneca-CICC Venture Capital
Inertia, location-driven construction management platform that provides solutions to alleviate jobsite productivity challenges, $13.2M
Mulligan Funding, financial services company providing small and medium-sized businesses with working capital, $5M
Lasso MD, martech platform for SMB healthcare practices, $2M Seed with Trestle Partners
Algenesis, material science and technology company that helps the planet recover from the pollution by-products made from fossil fuels, $1.3M